Published research has demonstrated that this peptide can activate the canonical Wnt pathway in dermal papilla cells, which are the signaling hub of the hair follicle
Which is why dermatology research protocols almost universally use SubQ for skin-targeted peptides, while IM remains the standard for systemic metabolic compounds like growth hormone secretagogues
This remains the most-cited clinical comparison for topical copper peptide efficacy
SubQ targets the adipose layer 48mm deep, avoiding the dense nerve networks in muscle tissue that cause post-injection soreness
The intertwined dysregulation of copper and iron metabolism further exacerbates the disease by promoting apoptosis in lipid-rich foam cells and VSMCs, which are particularly vulnerable to metal-dependent cell death [195, 196]
Weve found that the real GHK-Cu risks are linked to unregulated injectable products or even serums that wont tell you what exactly is in them